4
Changes in Ownership
Processa Pharmaceuticals, Inc. Filed Acc 0000897069-25-000789
Chief Development Officer gave up 3,311 shares (to pay taxes)
- Chief Development Officer acquired 15,059 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Bigora Sian · Chief Development Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-04-01 | Exercise or conversion : show line 1 in the form | +15,059 | 36,937 | D | ||
| 2025-04-01 | Shares withheld for taxes : show line 2 in the form | −3,311 | $0.41 | $1,364 | 33,626 | D |
Loading xslF345X05/form4.xml…